New injection shows promise for weight loss in diabetics
Disease control
Recruiting now
This study is testing whether a new injectable medication called VK2735 can help people with type 2 diabetes lose weight and better manage their condition. About 1,100 adults who are overweight or obese will receive either the medication or a placebo injection for 78 weeks. Resea…
Phase: PHASE3 • Sponsor: Viking Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC